Current State and Local Tax Expense (Benefit) of Hepion Pharmaceuticals, Inc. from 30 Jun 2016 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Hepion Pharmaceuticals, Inc. annual and quarterly Current State and Local Tax Expense (Benefit) in USD history and change rate from 30 Jun 2016 to 31 Dec 2024.
  • Hepion Pharmaceuticals, Inc. Current State and Local Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $3,000,000.
  • Hepion Pharmaceuticals, Inc. annual Current State and Local Tax Expense (Benefit) for 2024 was $2,969,252.
  • Hepion Pharmaceuticals, Inc. annual Current State and Local Tax Expense (Benefit) for 2019 was $11,400,000.
  • Hepion Pharmaceuticals, Inc. annual Current State and Local Tax Expense (Benefit) for 2017 was $1,600,000, a 16% decline from 2016.
Source SEC data
View on sec.gov
Current State and Local Tax Expense (Benefit), Annual (USD)
Current State and Local Tax Expense (Benefit), YoY Annual Change (%)
Current State and Local Tax Expense (Benefit), Quarterly (USD)

Hepion Pharmaceuticals, Inc. Annual Current State and Local Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,969,252 01 Jan 2024 31 Dec 2024 10-K 12 Mar 2026 2025 FY
2019 $11,400,000 01 Jan 2019 31 Dec 2019 10-K 31 Mar 2021 2020 FY
2017 $1,600,000 -$300,000 -16% 01 Jul 2016 30 Jun 2017 10-KT 26 Mar 2018 2017 FY
2016 $1,900,000 01 Jul 2015 30 Jun 2016 10-KT 26 Mar 2018 2017 FY

Hepion Pharmaceuticals, Inc. Quarterly Current State and Local Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $3,000,000 01 Jan 2024 31 Mar 2024 10-Q 19 May 2025 2025 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.